Federal News
FDA Extends Gluten Labeling Comment Deadline
March 24, 2026
The Food and Drug Administration (FDA) has extended the public comment period for its Request for Information (RFI) on gluten labeling and cross-contact in packaged foods from March 23, 2026, to April 22, 2026. This extension provides additional time for stakeholders, including food manufacturers, labeling consultants, and regulatory professionals, to submit detailed input on gluten-related labeling challenges, particularly concerning adverse reactions and cross-contact issues with oats. The FDA's solicitation aims to gather comprehensive data to inform potential regulatory updates or guidance on gluten labeling standards.
- Why this matters: Procurement professionals and contractors involved in food labeling, packaging, and compliance should note the extended deadline to contribute expertise or prepare for forthcoming regulatory changes.
- The extension signals ongoing FDA engagement in refining gluten labeling requirements, which may impact future contract specifications and compliance obligations.
- Companies providing labeling services or gluten testing may find opportunities to support clients responding to evolving FDA standards.
- Organizations should consider aligning product development and labeling strategies with potential FDA guidance emerging from this RFI process.
Agencies
Food and Drug Administration
Locations
Sources
- FDA Extends Comment Deadline on Gluten Labeling RFI · The National Law Review · Mar 24